Trading Outlook for Illumina Inc. Issued by StockPreacher.com

• Press Release
• Source: StockPreacher
• On 6:50 am EST, Tuesday November 3, 2009

DALLAS, Nov. 3, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Illumina Inc. (Nasdaq:ILMN - News). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

Related Quotes

Symbol	Price	Change
ILMN	27.99	+1.49

{"s" : "ilmn","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The investment report on Illumina Inc. (Nasdaq:ILMN - News) should be of particular interest to other biotechnology companies:

The full report is available at: http://www.stockpreacher.com/n/ILMN

Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher

Illumina Inc. (ILMN) is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that serve the sequencing, genotyping and gene expression markets. It also, develops and commercializes sequencing technologies used to perform a range of analyses, including whole genome re-sequencing, gene expression analysis and small ribonucleic acid (RNA) analysis.

Message Board Search for ILMN: http://www.boardcentral.com/boards/ILMN

In the report, the analyst notes:

"For the third quarter of 2009, the Company reported revenue of $158.4 million, a 5% increase over the $150.3 million reported in the third quarter of 2008. Product revenue was $150 million, growing 7% over the prior-year period led by significant growth in sequencing products. Consumables revenue for the quarter was $87 million compared to $90 million in the third quarter of 2008, which represents a year-over-year decline of 4%.Gross margin in the third quarter of 2009 was 67.6% compared to 62.0% in the comparable period of 2008.

"In July, the Company delivered the first human genome sequenced under its personal genome-sequencing service to a customer. ILMN said that it generated more than 110 gigabases of data, sequencing the genome to more than 30-fold coverage, at its CLIA-certified laboratory, which is also accredited by the College of American Pathologists, using its Genome Analyzer technology."

To read the entire report visit: http://www.stockpreacher.com/n/ILMN

StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com

StockPreacher.com Disclosure

StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly owned by BlueWave Advisors LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.

StockPreacher.com
Jeff Bishop
(469)-252-3505
press@beaconequity.com